Friday, October 11, 2019 About: ADVERUM BIOTECHNOLOGIES INC (Nasdaq: ADVM) is a clinical-stage gene therapy company targeting unmet medical needs in ocular and rare diseases, ADVM is set … [Read more...] about Incoming Data + Gartley
breakout
Biotech: Time To Buy the Bull
As the month of October begins and broader markets sold off, biotech stocks are still largely negative and/ or flat for the year. As seen in the LABU vs. LABD chart below, the spread between the two … [Read more...] about Biotech: Time To Buy the Bull
You must be logged in to post a comment.